secwatch.observer — SEC 8-K summary
======================================

Issuer:     EyePoint, Inc. (EYPT)
CIK:        0001314102
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0001193125-25-270145
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

EyePoint Pharmaceuticals files $200M ATM equity offering with Cantor Fitzgerald
-------------------------------------------------------------------------------

- Registered at-the-market offering of up to $200 million of common stock under a prospectus supplement filed November 6, 2025.
- Sales agreement with Cantor Fitzgerald & Co. dated August 5, 2020 governs the offering.
- Proceeds expected for general corporate purposes; legal opinion from Hogan Lovells filed as exhibit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1314102/000119312525270145/0001193125-25-270145-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1314102/000119312525270145/d80838d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-270145

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer